Chronic myeloid leukemia (CML) is a malignancy driven by the BCR::ABL1fusion gene, with the e19a2 transcript being a rare variant, accounting for 0.4% of CML cases. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.